D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 56 Citations 14,113 88 World Ranking 7164 National Ranking 563

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Enzyme
  • Biochemistry

Her main research concerns Biochemistry, Cyclin-dependent kinase, Kinase, Cyclin-dependent kinase 2 and Cyclin-dependent kinase 1. In the subject of general Biochemistry, her work in Cyclin-dependent kinase complex, Glycoprotein, Phosphorylation and Histone H3 is often linked to P-glycoprotein, thereby combining diverse domains of study. The Cyclin-dependent kinase study which covers Cyclin that intersects with Cyclin-dependent kinase 5.

Her Kinase study improves the overall literature in Cell biology. Her Cyclin-dependent kinase 2 research incorporates themes from Protein structure and Stereochemistry. Her Cyclin-dependent kinase 1 research incorporates elements of Molecular biology and Cell growth.

Her most cited work include:

  • The biochemistry of P-glycoprotein-mediated multidrug resistance. (1811 citations)
  • Protein kinase inhibitors: insights into drug design from structure. (1021 citations)
  • Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. (642 citations)

What are the main themes of her work throughout her whole career to date?

Jane A. Endicott spends much of her time researching Cyclin-dependent kinase, Cell biology, Cyclin-dependent kinase 2, Biochemistry and Kinase. Jane A. Endicott combines subjects such as Cyclin-dependent kinase 1, Binding site and Cyclin with her study of Cyclin-dependent kinase. The study incorporates disciplines such as Cancer research and Purine in addition to Cyclin-dependent kinase 1.

Her work deals with themes such as Protein structure, Cell cycle, Ubiquitin and Cyclin D, which intersect with Cell biology. She interconnects Stereochemistry and Mitogen-activated protein kinase kinase in the investigation of issues within Cyclin-dependent kinase 2. Her studies examine the connections between Kinase and genetics, as well as such issues in Computational biology, with regards to Drug discovery.

She most often published in these fields:

  • Cyclin-dependent kinase (37.01%)
  • Cell biology (36.36%)
  • Cyclin-dependent kinase 2 (30.52%)

What were the highlights of her more recent work (between 2013-2021)?

  • Cell biology (36.36%)
  • Cyclin-dependent kinase (37.01%)
  • Cyclin-dependent kinase 1 (15.58%)

In recent papers she was focusing on the following fields of study:

Jane A. Endicott mainly investigates Cell biology, Cyclin-dependent kinase, Cyclin-dependent kinase 1, Cyclin-dependent kinase 2 and Kinase. The concepts of her Cell biology study are interwoven with issues in Genetics, Structural motif, Mutant and Nuclear transport. Her Cyclin-dependent kinase study combines topics from a wide range of disciplines, such as Binding site and Cyclin.

Her Cyclin study incorporates themes from Computational biology and Protein kinase A. Her Cyclin-dependent kinase 2 research includes themes of Cancer research and Stereochemistry. Her Kinase study is concerned with Biochemistry in general.

Between 2013 and 2021, her most popular works were:

  • CDK1 structures reveal conserved and unique features of the essential cell cycle CDK. (83 citations)
  • CDK1 structures reveal conserved and unique features of the essential cell cycle CDK. (83 citations)
  • Structural insights into the functional diversity of the CDK–cyclin family (49 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Genetics

Jane A. Endicott mainly focuses on Cyclin-dependent kinase, Cell biology, Binding site, Cell cycle and Cyclin-dependent kinase 1. Her study in Kinase extends to Cyclin-dependent kinase with its themes. Her Kinase research includes elements of Apoptosis, Transcription and Cyclin.

Her studies deal with areas such as Nuclear transport, Cell nucleus, Importin, Nuclear protein and Ankyrin repeat as well as Cell biology. Her Binding site research integrates issues from Adenosine triphosphate, Druggability, Pharmacophore, Stereochemistry and Structure–activity relationship. Her Cyclin-dependent kinase 1 research focuses on Cyclin-dependent kinase 2 and how it relates to Conformational energy, Non-competitive inhibition and Transferase.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The biochemistry of P-glycoprotein-mediated multidrug resistance.

Jane A. Endicott;Victor Ling.
Annual Review of Biochemistry (1989)

2698 Citations

Protein kinase inhibitors: insights into drug design from structure.

Martin E. M. Noble;Jane A. Endicott;Louise N. Johnson.
Science (2004)

1509 Citations

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

Ralph Hoessel;Sophie Leclerc;Jane A. Endicott;Martin E. M. Nobel.
Nature Cell Biology (1999)

948 Citations

Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

James H. Gerlach;Jane A. Endicott;Peter F. Juranka;Graham Henderson;Graham Henderson.
Nature (1986)

794 Citations

The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases

Nick R. Brown;Martin E. M. Noble;Jane A. Endicott;Louise N. Johnson.
Nature Cell Biology (1999)

632 Citations

The Structural Basis for Control of Eukaryotic Protein Kinases

Jane A. Endicott;Martin E.M. Noble;Louise N. Johnson.
Annual Review of Biochemistry (2012)

381 Citations

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2.

Alison M. Lawrie;Martin E.M. Noble;Paul Tunnah;Nicholas R. Brown.
Nature Structural & Molecular Biology (1997)

307 Citations

Molecular Basis for the Recognition of Phosphorylated and Phosphoacetylated Histone H3 by 14-3-3

Neil Macdonald;Julie P.I. Welburn;Martin E.M. Noble;Anhco Nguyen.
Molecular Cell (2005)

265 Citations

Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles.

C.E Arris;F.T Boyle;A.H Calvert;N.J Curtin.
Journal of Medicinal Chemistry (2000)

254 Citations

Effects of Phosphorylation of Threonine 160 on Cyclin-dependent Kinase 2 Structure and Activity

Nicholas R. Brown;Martin E.M. Noble;Alison M. Lawrie;May C. Morris.
Journal of Biological Chemistry (1999)

253 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jane A. Endicott

Laurent Meijer

Laurent Meijer

Perha Pharmaceuticals

Publications: 121

Victor Ling

Victor Ling

BC Cancer Research Centre

Publications: 64

David I. Stuart

David I. Stuart

University of Oxford

Publications: 54

Ira Pastan

Ira Pastan

Center for Cancer Research

Publications: 45

Michael M. Gottesman

Michael M. Gottesman

National Institutes of Health

Publications: 41

Christian Doerig

Christian Doerig

RMIT University

Publications: 38

Takashi Tsuruo

Takashi Tsuruo

Japanese Foundation For Cancer Research

Publications: 37

Jonathan M. Grimes

Jonathan M. Grimes

University of Oxford

Publications: 30

Stefan Knapp

Stefan Knapp

Goethe University Frankfurt

Publications: 29

Raymond J. Owens

Raymond J. Owens

University of Oxford

Publications: 27

Miroslav Strnad

Miroslav Strnad

Palacký University, Olomouc

Publications: 25

Peter M. Fischer

Peter M. Fischer

University of Nottingham

Publications: 22

Alexios-Leandros Skaltsounis

Alexios-Leandros Skaltsounis

National and Kapodistrian University of Athens

Publications: 22

Louise N. Johnson

Louise N. Johnson

University of Oxford

Publications: 22

Nathanael S. Gray

Nathanael S. Gray

Stanford University

Publications: 21

Philipp Kaldis

Philipp Kaldis

Lund University

Publications: 20

Trending Scientists

Peter V. Gehler

Peter V. Gehler

Amazon (Germany)

Robert Černý

Robert Černý

Czech Technical University in Prague

Yu Lei

Yu Lei

Sun Yat-sen University

Paul Yager

Paul Yager

University of Washington

Brian N. Cox

Brian N. Cox

Rockwell Automation (United States)

Barbara J. Bond

Barbara J. Bond

Oregon State University

Sebastián Albertí

Sebastián Albertí

University of the Balearic Islands

Irmeli Lautenschlager

Irmeli Lautenschlager

University of Helsinki

Sébastien Zaragosi

Sébastien Zaragosi

University of Bordeaux

Marleen Verhoye

Marleen Verhoye

University of Antwerp

Jeremy D. Coplan

Jeremy D. Coplan

SUNY Downstate Medical Center

Raymond M. Klein

Raymond M. Klein

Dalhousie University

Clyde W. Dent

Clyde W. Dent

University of Southern California

Michael C. Stallings

Michael C. Stallings

University of Colorado Boulder

David Tall

David Tall

University of Warwick

Ioana A. Cristea

Ioana A. Cristea

University of Pavia

Something went wrong. Please try again later.